Rigshospitalet, Denmark: Heart Failure trials

The registry lists 14 Heart Failure studies with Rigshospitalet, Denmark as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 1Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Conduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization TherapyRecruitingNCT07492979Not applicable
• Optimal Settings for Anti Tachycardia Pacing (ATP) on ICDRecruitingNCT07354347Not applicable
• Screening for Advanced Heart Failure IN Stable ouTpatientS - The SAINTS StudyRecruitingNCT05299879
• Prognostic Value of BNP in MCS - a 25 Year Follow up StudyRecruitingNCT04377854
• PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist DevicesStatus unknownNCT04423562
• Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.CompletedNCT04409119Not applicable
• Direct HIS-pacing as an Alternative to BiV-pacing in Symptomatic HFrEF Patients With True LBBBCompletedNCT03614169Not applicable
• Effects of Increased CF-LVAD Pump Speed During Sustained Submaximal ExerciseCompletedNCT02335684Not applicable
• Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.CompletedNCT02303236
• Optimal Cardiac Resynchronization Therapy Pacing RateCompletedNCT02258061Early Phase 1
• Optimizing Continuous-flow Left Ventricular Assist Device Settings and Identification of Pump Malfunction - A Comparative Study of Echocardiography and Invasive HemodynamicsCompletedNCT01851889
• The Increase Study. Effect of Incremental Versus Fixed Pump on Peak Oxygen Consumption in Heart Failure Patients Supported With a Continuous Flow Left Venticular Assist DeviceCompletedNCT01698398Not applicable
• Ability of Metoprolol to Alter the Exercise Induced Elevation of CatecholaminesStatus unknownNCT00885651Phase 4
• Autologous Mesenchymal Stromal Cell Therapy in Heart FailureCompletedNCT00644410Phase 1/2